8-K - DiaMedica Therapeutics Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On August 12, 2025, DiaMedica Therapeutics Inc. (the “Company”) entered into a Sales Agreement (the “Sales Agreement

Material Agreement

$100.0M

9.01

. Financial Statements and Exhibits. (d) Exhibits. The following exhibit is furnished herewith: Exhibit Number Description 5.1 Opinion of Pushor Mitchell (Incor

Exhibits Only

Exhibits (1)

8-K

FORM 8-K